Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
View ORCID ProfileClaire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, View ORCID ProfileMatthew R. Baldwin, Christine Kim Garcia
doi: https://doi.org/10.1101/2021.03.17.21253834
Claire F. McGroder
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
David Zhang
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
Mohammad A. Choudhury
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
Mary M. Salvatore
2Department of Radiology, Columbia University Irving Medical Center
Belinda M. D’Souza
2Department of Radiology, Columbia University Irving Medical Center
Eric A. Hoffman
3Deparment of Radiology, University of Iowa Carver College of Medicine, Iowa City, Iowa
4Department of Internal Medicine, and University of Iowa Carver College of Medicine, Iowa City, Iowa
5Department of Biomedical Engineering, University of Iowa Carver College of Medicine, Iowa City, Iowa
Ying Wei
6Department of Biostatistics, Columbia University Irving Medical Center
Matthew R. Baldwin
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
Christine Kim Garcia
1Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center
7Institute of Genomic Medicine, Columbia University Irving Medical Center
8Center for Precision Medicine and Genomics, Columbia University Irving Medical Center
Posted March 20, 2021.
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
Claire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia
medRxiv 2021.03.17.21253834; doi: https://doi.org/10.1101/2021.03.17.21253834
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
Claire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia
medRxiv 2021.03.17.21253834; doi: https://doi.org/10.1101/2021.03.17.21253834
Subject Area
Subject Areas
- Addiction Medicine (369)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2748)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12397)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4259)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2756)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4035)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (468)
- Public and Global Health (6650)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)